Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Chandan Reddy

Neurological Surgery Celebration, FL Medical Doctor

NPI 1356558175 CMS profile 828744

400 Celebration Pl Ste A360, Celebration, FL 34747

Open in the dashboard

General payments

$9,600

219 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Chandan Reddy of Celebration, FL is reported in the CMS Open Payments database as having received $9,600 across 219 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 69th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,879 44
2024 General $2,119 38
2023 General $1,030 28
2022 General $1,450 32
2021 General $1,651 39
2020 General $861 29
2019 General $610 9

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Chandan Reddy
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Chandan Reddy were reported at $1,879. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Chandan Reddy Neurological Surgery median Middle half National median
2019 $610 $582 $138–$3,006 $163
2020 $861 $294 $76–$2,174 $114
2021 $1,651 $387 $105–$2,432 $132
2022 $1,450 $542 $139–$2,989 $149
2023 $1,030 $534 $145–$2,697 $160
2024 $2,119 $574 $155–$3,046 $164
2025 $1,879 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. InSightec,Inc $2,519 26 payments
  2. Abbott Laboratories $1,451 25 payments
  3. Boston Scientific Corporation $841 33 payments
  4. Stryker Corporation $572 16 payments
  5. Medtronic USA, Inc. $561 21 payments
  6. Carlsmed, Inc. $557 18 payments
  7. Globus Medical, Inc. $556 4 payments
  8. Medtronic, Inc. $478 17 payments
  9. DePuy Synthes Sales Inc. $385 10 payments
  10. SI-BONE, Inc. $225 5 payments
  11. Other $1,455 44 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $8,009 213 payments
  2. Travel and Lodging $1,571 5 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $19 1 payment
Products named General payments · program years 2019–2025
  1. Exablate Neurology $1,282 11 payments
  2. EXABLATE Neurology $1,237 15 payments
  3. INFINITY $676 6 payments
  4. Excelsius - GPS $515 3 payments
  5. aprevo $469 14 payments
  6. Proclaim IPG $336 4 payments
  7. WaveWriter Alpha Prime 16 $271 10 payments
  8. INTELLIS $241 4 payments
  9. KYPHON Balloon Kyphoplasty $237 13 payments
  10. IFUSE IMPLANT $225 5 payments
  11. Other $4,311 147 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 7 drugs

Part D claims

220

Median for Neurosurgery: 83

Drug cost

$2,372

Median for Neurosurgery: $872

Branded share of claims

36.4%

Median for Neurosurgery: 16.5%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 55 $843
Gabapentin Generic 54 $585
Methocarbamol Generic 37 $477
Tramadol Hcl Generic 16 $153
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 25 $132
Methylprednisolone Generic 15 $98
Cephalexin Generic 18 $83

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,779 Part D prescribers listed as Neurosurgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 66 billing codes

Paid by Medicare

$213,753

Medicare's payments for the services billed

Medicare patients

337

Average age 73

Services billed

623

150 women, 187 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 74%
Ischemic heart disease 42%
Diabetes 38%
Depression 37%
Chronic kidney disease 36%
Cancer 24%
COPD 23%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

219 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record